This study applied dynamic [11C]UCB-J PET to derive both binding potential (BPND) as an index of synaptic density and relative tracer delivery (R1) as an index of relative perfusion in 30 Parkinson’s disease (PD) participants and 30 control participants. A spatial covariance analysis performed on R1 images identified a Parkinson’s disease–related perfusion pattern (PDRP), a network-level alteration previously described in metabolic imaging literature but here derived from perfusion-like information available from dynamic SV2A PET.
PDRP expression was significantly higher in PD than in controls (p = 1.7 × 10−5) with a large effect size (Cohen’s d = 1.2). Expression of this R1-derived PDRP correlated with motor symptom severity measured by MDS‑UPDRS III (r = 0.57, p = 0.0009), indicating that higher network expression relates to worse overall motor scores in this cohort.
The investigators tested whether combining the complementary biomarkers—network perfusion expression (PDRP) and focal synaptic density loss—better explained motor symptom variation in PD. Synaptic density in the substantia nigra was measured using BPND derived from dynamic [11C]UCB-J PET. When PDRP expression scores were combined with nigral synaptic density in linear models, the two measures together explained 48% of the total variation in MDS‑UPDRS Part III scores.
The authors note this combined explanatory power is approximately twice that reported previously when using nigral synaptic density alone, indicating that adding a perfusion‑network measure captures additional disease-relevant physiology associated with motor severity.
Tremor is a prominent motor feature of PD that often shows weak correlation with dopaminergic measures. To identify physiological correlates of tremor severity, whole‑brain cluster analyses were performed using R1 values. Two large clusters in occipital‑parietal regions were identified where R1 correlated negatively with tremor severity (cluster-level p k < 1 × 10−6; correlation magnitude r ≈ −0.65, p < 0.001). These findings suggest that lower relative perfusion in occipital‑parietal cortex is associated with worse tremor in this sample.
The negative R1–tremor correlations indicate a perfusion signature that may be linked to tremor pathophysiology independent of nigrostriatal dopaminergic loss. The source does not report additional mechanistic detail beyond these regional associations.
Beyond univariate regional effects, the study examined alterations in inter-individual regional correlation structure for both BPND and R1 measures. The analysis revealed extensive correlation differences in PD compared with controls. Synaptic density correlation alterations prominently involved the pallidum, while perfusion correlation alterations prominently involved the thalamus. These network‑level changes point to distributed physiological disruptions in PD across both synaptic and perfusion domains as measured by dynamic SV2A PET.
The report does not provide numerical matrices or exhaustive lists of all altered region–region correlations in the abstract; readers are referred to the full data or supplementary material for detailed correlation maps.
Participants: The analysis included 30 PD participants and 30 control participants imaged with dynamic [11C]UCB-J PET. The study derived BPND images as a proxy for synaptic density and R1 images as an index of relative perfusion from the same dynamic PET acquisitions.
Analytic approaches: A spatial covariance technique was applied to R1 images to derive the PDRP. Linear regression models related motor severity (MDS‑UPDRS Part III) to PDRP expression and substantia nigra synaptic density. Whole‑brain cluster analyses tested voxelwise associations between R1 and tremor severity. Inter‑individual regional correlation matrices for both BPND and R1 were compared between PD and control groups to identify altered correlation patterns.
Specific acquisition parameters, preprocessing steps, statistical thresholds beyond those reported in the abstract, and detailed model covariates are not provided in the source abstract and would need to be consulted in the full manuscript or supplementary materials.
Ethics: Yale University Human Investigation Committee/Institutional Review Board and the Radiation Safety Committee at Yale University provided ethical approval for this study. All participants provided informed consent.
Data availability: Raw data supporting the analyses are available from the principal investigator (Dr. David Matuskey) upon request, per the source document.
Funding and competing interests: The work was supported by the National Institute of Neurological Disorders and Stroke (R01NS124819) and AbbVie. Two authors (Robert Comley and Sjoerd J. Finnema) are full‑time employees of AbbVie; the authors stated that this employment does not constitute a conflict for the reported research. All other authors declared no conflicts of interest.
The authors conclude that combining synaptic density and perfusion outcomes from dynamic [11C]UCB-J PET provides complementary information about physiological alterations in PD. Specifically, integrating a perfusion-derived network measure (PDRP) with nigral synaptic density substantially increases the explained variance in motor symptom severity compared with measures of synaptic loss alone. Additionally, regional perfusion signatures in occipital‑parietal cortex were associated with tremor severity, and altered inter-regional correlation patterns were observed for both synaptic density and perfusion measures. The abstract does not report longitudinal data, treatment effects, or external validation; readers should consult the full manuscript for further methodological detail and comprehensive results.